Exchange Surveillance
No active ASM or GSM measures on this stock.
Price band ± 20%
Price
Trading Data
range barsReturns
absolute and vs benchmark indexAbout the Company
Bajaj Healthcare Ltd mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries. The various product categories include chlorhexidine products, minerals and nutritional supplements, anti convulsants, anti asthamatics and directly compressible grade materials.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- Thane, Maharashtra
- Chairman
- Sajankumar R Bajaj
- CEO & MD
- Sajankumar R Bajaj
- Registrar
- Sharex Dynamic (India) Pvt. Ltd.
- Exchange
- NSE
- ISIN
- INE411U01027
Institutional Demand
passive ownership through ETFsContext
where this company sitsFrequently Asked
▶What is the share price of Bajaj Healthcare Ltd today?
Bajaj Healthcare Ltd (BAJAJHCARE) is trading at ₹312.6. The price shown is the latest available from the exchange feed and updates through the trading session.
▶What is BAJAJHCARE’s P/E ratio versus the sector?
BAJAJHCARE trades at a P/E of 19.1. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.
▶What is BAJAJHCARE’s dividend yield?
BAJAJHCARE has a dividend yield of 0.47%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.
▶What is BAJAJHCARE’s 52-week high and low?
BAJAJHCARE has traded between ₹272.35 and ₹488.9 over the past year. The Trading Data block shows where the current price sits inside that band.
▶What is the market capitalisation of Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd has a market capitalisation of ₹1,077 crore.
▶What is BAJAJHCARE’s return on equity?
BAJAJHCARE reports a return on equity of 8.3%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - Specialty & Generic.
▶Who are BAJAJHCARE’s competitors?
The Peers block on this page lists other Drug Manufacturers - Specialty & Generic companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.
▶What is BAJAJHCARE’s promoter holding?
Promoters hold 58.59% of BAJAJHCARE. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.
▶Which indices include BAJAJHCARE?
Index membership is listed in the Context block on this page, along with the weight BAJAJHCARE carries in each. That weight is what determines how much passive money tracks the stock.
▶Is Bajaj Healthcare Ltd a good buy?
We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from BAJAJHCARE’s own numbers. The judgement is yours.
BAJAJHCARE at a glance
Bajaj Healthcare Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector. Bajaj Healthcare Ltd (BAJAJHCARE) last traded at ₹312.6, giving it a market capitalisation of ₹1,077 crore. The 52-week range is ₹272.35 to ₹488.9, and the price is 19% of the way up that range. It trades at a price-to-earnings ratio of 19.1. Promoters hold 58.59% of the company in the latest shareholding filing.
| Market cap | ₹1,077 crore |
|---|---|
| P/E | 19.1 |
| ROE | 8.3% |
| ROCE | 11.5% |